Eli Lilly and Co (NYSE: LLY) has been offered an AA credit score by analysts at Morningstar. The investment research companies AA score recommends that the company is a very-low default danger. They also gave their stock a four star score.
Eli Lilly and (NYSE: LLY) opened at 72.48 on Thursday. Eli Lilly and has a YEAR low of $69.60 and a 12 month high of $92.85. The stock has a market capitalization of $76.49 billion and a P/E ratio of 32.07. The companies 50-day moving average is $74.35 and its 200-day moving average is $80.67.
Eli Lilly and (NYSE: LLY) last revealed its quarterly incomes data on Thursday, January 28th. The company reported $0.78 incomes per share (EPS) for the quarter, meeting experts consensus quotes of $0.78. The company had revenue of $5.38 billion for the quarter, compared to experts expectations of $5.33 billion. During the very same duration in 2014, the company earned $0.75 incomes per share. The companys quarterly income was up 5.0 % compared to the exact same quarter last year. Generally, equities experts anticipate that Eli Lilly and will post $3.54 incomes per share for the present financial year.
In associated news, SVP Stephen F. Fry offered 15,230 shares of the firms stock in a deal on Friday, February 5th. The shares were offeredcost an average price of $78.87, for an overall value of $1,201,190.10. Following the conclusion of the transaction, the senior vice president now directly owns 59,690 shares of the companys stock, valued at $4,707,750.30. The deal was revealed in a legal filing with the SEC, which is readily available at the SEC site. Likewise, Director Jackson P. Tai purchased 3,170 shares of the businesss stock in a deal that took place on Monday, February 1st. The stock was obtained at a typical cost of $78.62 per share, with an overall value of $249,225.40. Following the conclusion of the acquisition, the director now owns 39,487 shares of the business stock, valued at around $3,104,467.94. The disclosure for this purchase can be discovered here.
Other equities experts have also recently released research study reports about the stock. Zacks Financial investment Research study cut shares of Eli Lilly and from a buy rating to a hold rating in a research note on Wednesday, December 23rd. Vetr cut shares of Eli Lilly and from a strong-buy rating to a buy rating and set a $88.69 cost objective for the business. in a research study note on Tuesday, January 19th. Piper Jaffray repeated an obese score and set a $121.00 target price on shares of Eli Lilly and in a research report on Friday, November 20th. Leerink Swann repeated a buy score on shares of Eli Lilly and in a research report on Tuesday, December 29th. Finally, Credit Suisse restated an outperform rating on shares of Eli Lilly and in a research study report on Monday, January 25th. Five financial investment experts have rated the stock with a hold rating and sixteen have released a buy score to the stock. The business has an average rating of Buy and an agreement rate target of $96.80.
Eli Lilly and Business (NYSE: LLY) is … Read the rest